A7.24 The Pentanucleotide Insertion in HSPA1B Gene is Associated with Idiopathic Inflammatory Myopathy. (25th February 2013)

• Record Type: Journal Article
• Authors: Svitalkova, T; Remakova, M; Faustova, M; Plestilova, L; Mann, H; Vencovsky, J; Novota, P
• Is Part Of: Annals of the rheumatic diseases. Volume 72:Supplement 1(2013)
• Page Start: A56
• Page End: A56
• Publication Date: 2013-02-25
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2013-203221.24
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background and Objectives: The HSPA1B gene is one of the three HSP70 genes located within the Major Histocompatibility Complex (MHC) on chromosome 6p21. The HSP70 molecules in their intracellular form have antiapoptotic function and are responsible for stabilisation of protein structure; in their extracellular form, they act as mediators of immune response. The extracellular HSPs are part of the innate and adaptive immune response and are involved in the process of antigen presentation. The aim of our study was to find out if an association between polymorphisms of MHC located HSP70 genes and subgroups of idiopathic inflammatory myopathy exists. Materials and Methods: We have analysed 177 patients suffering from idiopathic inflammatory myopathy (82 patients with dermatomyositis – DM, 71 patients with polymyositis – PM, 22 patients with cancer associated myositis, 2 patients with inclusion body myositis) and 59 healthy controls. In total, six genetic polymorphisms located within the three HSP70 genes were analysed by direct genomic DNA sequencing. The statistical analysis was done using Fisher's exact test with calculated p < 0.05 considered as statistically significant. Results and Conclusions: The frequency of the "INS" allele of the pentanucleotide insertion polymorphism in HSPA1B (Rs9281590) was increased in patients suffering from myositis (43.79%) in comparison with controls (32.20%; p < 0.05). The Odds Ratio calculated for this polymorphism was 1.64 (CI95% 1.056; 2.545). Its increased frequency was predominantly found in DM patients (p < 0.05); the allele distribution in PM patients did not significantly differ from controls. Presence of INS allele was strongly related to the well described HLA associated risk, the HLA-DRB1*03 allele (p < 0.001), found mostly in PM patients. INS allele is independent on other myositis associated HLA allele, HLA-DRB1*16, found increased in the population of our DM patients. Other polymorphisms analysed in this study did not show any relation to the myositis. Our findings support the hypothesis, that DM and PM have partially different genetic background. Acknowledgement: This work is supported by Internal Grant Agency of Ministry of Health of the Czech Republic NT/13699.